Mitesh

In response to a significant ongoing disruption to the supply of some strengths of Estradot® patches, three Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 19th December 2024, SSP079, provides that for every Estradot® 50micrograms/24hours patch originally prescribed either one Evorel® 50 patch or one [...]

The post Three new SSPs issued for Estradot® patches appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) Drug alert number: EL (24)A/63 Date issued: 19 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Vyvgart 1000 mg solution for injection (Argenx BV) DMRC reference number: DMRC-34131563 Company name:Argenx [...]

The post MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 5 December 2024) has been published and includes articles on: Letters and medicine recalls sent to healthcare professionals in November 2024 To see th...

In response to a significant ongoing disruption to the supply of Cefalexin 125mg/5ml oral suspension sugar free and Cefalexin 250mg/5ml oral suspension sugar free, two Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 10 December 2024, SSP077 provides that for every 5 ml of Cefalexin 125mg/5ml [...]

The post Two SSPs issued for Cefalexin oral suspension sugar free appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter on 3 December 2024 advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and [...]

The post DHSC permits use of antiviral medicines against influenza appeared first on Community Pharmacy England.